TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
OLMA

Olema Pharmaceuticals Inc

Healthcare · Biotechnology

9.60$ -1.9% vs. previous close Closing price · As of: Sep 21, 2026

Statements

Balance Sheet

All figures as a percentage of total assets in the same period.

Tick rows to compare them in a chart (up to 4)

Balance Sheet OLMA
Line item 2018 2019 2020 2021 2022 2023 2024 2025
100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0%
99.1% 78.0% 99.8% 98.2% 96.9% 96.2% 97.2% 96.6%
96.3% 51.5% 98.8% 4.7% 11.0% 24.7% 30.9% 9.1%
96.3% 51.5% 98.8% 97.1% 94.8% 94.5% 96.3% 94.8%
0.0% 0.1% 0.2% 0.5% 0.8%
-0.1% -0.1% -0.9%
0.8% 19.7% 0.0% 1.6% 0.7%
0.2%
291.9% 8,125.8% 1.3% 3.8% 8.4% 8.3% 9.3% 10.3%
6.1% 1,043.9% 1.3% 3.0% 7.7% 7.8% 9.3% 9.7%
0.3% 0.5% 0.4% 0.3% 0.2%
3.5% 708.3% 0.2% 0.0% 0.2% 1.0% 1.0% 1.7%
0.6%
-191.9% -8,025.8% 98.7% 96.2% 91.6% 91.7% 90.7% 89.7%
-197.1% -8,153.0% -9.7% -35.2% -96.9% -110.4% -96.5% -112.0%
431.0% 30,431.6% 11.5% 13.4% 18.5% 16.3% 13.0% 16.3%

Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?